Determination of acyclovir in human plasma by high-performance liquid chromatography

被引:57
作者
Boulieu, R [1 ]
Gallant, C [1 ]
Silberstein, N [1 ]
机构
[1] HOP NEUROCARDIOL,SERV PHARMACEUT,F-69394 LYON 03,FRANCE
来源
JOURNAL OF CHROMATOGRAPHY B | 1997年 / 693卷 / 01期
关键词
acyclovir;
D O I
10.1016/S0378-4347(97)00037-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A selective and sensitive isocratic high-performance liquid chromatographic method for the analysis of acyclovir in human plasma was described. Acid deproteinisation was used as sample treatment. Mean analytical recoveries were higher than 94% at low and high concentrations, The quantification limit was 0.1 mg/l for a plasma volume of 500 mu l and precision study exhibits coefficients of variation lower than 5%. The method is suitable for therapeutic monitoring of acyclovir concentrations in organ-transplant recipients.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 14 条
[1]  
BENNASR S, 1992, THERAPIE, V47, P223
[2]   MODIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF GANCICLOVIR IN PLASMA FROM PATIENTS WITH SEVERE RENAL IMPAIRMENT [J].
BOULIEU, R ;
BLEYZAC, N ;
FERRY, S .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 571 (1-2) :331-333
[3]   SELECTIVITY OF ACTION OF AN ANTI-HERPETIC AGENT, 9-(2-HYDROXYETHOXYMETHYL)GUANINE [J].
ELION, GB ;
FURMAN, PA ;
FYFE, JA ;
DEMIRANDA, P ;
BEAUCHAMP, L ;
SCHAEFFER, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5716-5720
[4]   NEUROTOXICITY OF ACYCLOVIR IN END STAGE RENAL-DISEASE [J].
GILL, MJ ;
BURGESS, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (02) :300-301
[5]   STRATEGIES FOR PREVENTION OF INFECTION AFTER CARDIAC TRANSPLANTATION [J].
KEATING, MR ;
WILHELM, MP ;
WALKER, RC .
MAYO CLINIC PROCEEDINGS, 1992, 67 (07) :676-684
[6]   SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF 9-(2-HYDROXYETHOXYMETHYL)GUANINE (ACYCLOVIR) IN HUMAN-PLASMA AND URINE [J].
LAND, G ;
BYE, A .
JOURNAL OF CHROMATOGRAPHY, 1981, 224 (01) :51-58
[7]  
MARSCHER H, J CHROMATOGR, V583, P122
[8]   COMPARATIVE PHARMACOKINETICS OF ANTIVIRAL NUCLEOSIDE ANALOGS [J].
MORSE, GD ;
SHELTON, MJ ;
ODONNELL, AM .
CLINICAL PHARMACOKINETICS, 1993, 24 (02) :101-123
[9]  
NEBINGER P, J CHROMATOGR, V619, P342
[10]  
SALAMOUN J, 1987, J CHROMATOGR-BIOMED, V420, P197